Female Lung Cancer is on the Rise in Europe, Reveals Synovate Healthcare Global Tandem Oncology Monitor
November 30th, 2006
Data from the European arm of the Synovate Healthcare Global Tandem Oncology Monitor (GTOM) reveals a rise in female lung cancer across Europe’s five largest drug-treated oncology markets: the UK, France, Germany, Italy and Spain. In 2006 women now comprise almost 25% of lung cancer patients – this is up from 18% in 2001, representing a 7% growth in just five years.